Technique recovers lost single-cell RNA-sequencing information
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
Using these new particles, researchers could develop treatments for heart disease and other conditions.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Molecular biologist and professor emerita advocates for more inclusive science and advises how to get there.
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.
MIT engineers devise a temporary film that may help treat diabetes, infections, and other conditions.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
A new computational method fine-tunes delivery of therapeutics to specific brain regions.
The prototype mask, which includes an N95 filter, can be easily sterilized and worn many times.
MIT engineers are using computing modeling to prevent microparticles from clogging during injections.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.